European Healthtech startup funding raised during December 2024.
In December 2024, 40 European Healthtech companies raised a combined €916M across 40 funding rounds, up 265.3% versus December 2023. Switzerland led by capital raised, and Forbion was the most active investor. Data as of 9 Jul 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Cimeio Therapeutics | Other | Dec 2024 | €282M |
| ŌURA | Series D+ | Dec 2024 | €192M |
| Citryll | Series B | Dec 2024 | €85M |
| Antag Therapeutics | Series A |
| Dec 2024 |
| €80M |
| Aqemia | Other | Dec 2024 | €36M |
| Inotec Amd | Series C | Dec 2024 | €31M |
| Midiagnostics | Series D+ | Dec 2024 | €30M |
| Noema Pharma | Series B | Dec 2024 | €29M |
| Lion (Spiden) | Series A | Dec 2024 | €24M |
| Biomemory | Other | Dec 2024 | €17M |
| CarboCode | Series C | Dec 2024 | €15M |
| Orakl Oncology | Seed | Dec 2024 | €11M |
| Refoxy Pharmaceuticals | Seed | Dec 2024 | €9.1M |
| Abselion | Series A | Dec 2024 | €8.0M |
| Nua Surgical | Series A | Dec 2024 | €6.5M |
